Abstract:BACKGROUND:The high heterogeneity of triple negative breast cancer (TNBC) is the main clinical challenge for individualized therapy. Considering that fatty acid metabolism (FAM) plays an indispensable role in tumorigenesis and development of TNBC, we proposed a novel FAM-based classification to characterize the tumor microenvironment immune profiles and heterogeneous for TNBC.METHODS:Weighted gene correlation network analysis (WGCNA) was performed to identify FAM-related genes from 221 TNBC samples in Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) dataset. Then, non-negative matrix factorization (NMF) clustering analysis was applied to determine FAM clusters based on the prognostic FAM-related genes, which chosen from the univariate/multivariate Cox regression model and the least absolute shrinkage and selection operator (LASSO) regression algorithm. Then, a FAM scoring scheme was constructed to further quantify FAM features of individual TNBC patient based on the prognostic differentially expressed genes (DEGs) between different FAM clusters. Systematically analyses were performed to evaluate the correlation between the FAM scoring system (FS) with survival outcomes, genomic characteristics, tumor microenvironment (TME) features and immunotherapeutic response for TNBC, which were further validated in the Cancer Genome Atlas (TCGA) and GSE58812 datasets. Moreover, the expression level and clinical significancy of the selected FS gene signatures were further validated in our cohort.RESULTS:1860 FAM-genes were screened out using WGCNA. Three distinct FAM clusters were determined by NMF clustering analysis, which allowed to distinguish different groups of patients with distinct clinical outcomes and tumor microenvironment (TME) features. Then, prognostic gene signatures based on the DEGs between different FAM clusters were identified using univariate Cox regression analysis and Lasso regression algorithm. A FAM scoring scheme was constructed, which could divide TNBC patients into high and low-FS subgroups. Low FS subgroup, characterized by better prognosis and abundance with effective immune infiltration. While patients with higher FS were featured with poorer survival and lack of effective immune infiltration. In addition, two independent immunotherapy cohorts (Imvigor210 and GSE78220) confirmed that patients with lower FS demonstrated significant therapeutic advantages from anti-PD-1/PD-L1 immunotherapy and durable clinical benefits. Further analyses in our cohort found that the differential expression of CXCL13, FBP1 and PLCL2 were significantly associated with clinical outcomes of TNBC samples.CONCLUSIONS:This study revealed FAM plays an indispensable role in formation of TNBC heterogeneity and TME diversity. The novel FAM-based classification could provide a promising prognostic predictor and guide more effective immunotherapy strategies for TNBC.

Expression Level of Novel Tumor Suppressor Gene Fats is Associated with the Outcome of Node Positive Breast Cancer

The Value of FATS Expression in Predicting Sensitivity to Radiotherapy in Breast Cancer

FAT10 Level in Human Gastric Cancer and Its Relation with Mutant P53 Level, Lymph Node Metastasis and TNM Staging.

Expressions of FATI0 and P53 Mutant in Human Gastric Cancer and Their Relations

The relationship between FAT10 mRNA expression and feature of clinical pathology in gastric carcinoma

High FAS Expression Correlates with a Better Prognosis and Efficacy of Taxanes and Target Regents in Breast Cancer

FEAT Expression Correlates with Tumor Size, PR Status, HER2 Expression, Ki67 Index, and Molecular Subtype and Predicts Recurrence in Breast Cancer

FATS is a transcriptional target of p53 and associated with antitumor activity

FAT1 Upregulation is Correlated with an Immunosuppressive Tumor Microenvironment and Predicts Unfavorable Outcome of Immune Checkpoint Therapy in Non-Small Cell Lung Cancer

Fats Regulates Polyamine Biosynthesis By Promoting Odc Degradation In An Er Beta-Dependent Manner In Non-Small-Cell Lung Cancer

Loss of Fragile Site-Associated Tumor Suppressor Promotes Antitumor Immunity Via Macrophage Polarization

FATS inhibits the Wnt pathway and induces apoptosis through degradation of MYH9 and enhances sensitivity to paclitaxel in breast cancer

FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer

Overexpression of the Fat Mass and Obesity Associated Gene (fto) in Breast Cancer and Its Clinical Implications

Clinicopathological Significance of Fragile Histidine Triad Transcription Protein Expression in Breast Carcinoma.

FAS gene expression, prognostic significance and molecular interactions in lung cancer

Functional Domain Mutations in FAT4 Cadherin 21-34 Predicts Improved Prognosis in Gastric Cancer Patients: A Retrospective Study

FAT2 is a Novel Independent Prognostic Factor for the Poor Prognosis of Gastric Carcinoma.

Loss Expression of Active Fragile Sites Genes Associated with the Severity of Breast Epithelial Abnormalities.

A Novel Fatty-Acid Metabolism-Based Classification for Triple Negative Breast Cancer

Over-Expression and Prognostic Significance of FATP5, as a New Biomarker, in Colorectal Carcinoma